When that fat is lost, the cheeks and the jawline are going to go in the direction of gravity. For these patients, he suggests treatments designed to restore volume in the face, such as fillers or biostimulators that encourage your body to regenerate its own tissue
The study concludes that strategies aimed at improving dopamine function could be beneficial in treating obesity
References: Gibson GR et al., Gut, 2017 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation
When undergoing treatment with GLP-1 analogues like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide for obesity and type 2 diabetes management, regularly measuring and monitoring your blood biomarkers becomes vital
He added, As with all obesity treatments, including medications and bariatric surgery, long-term success depends on integrating these interventions with healthy eating, regular physical activity, and ongoing behavioral support. Other reasons to stop semaglutide treatment include being unable to tolerate side effects, taking a contraindicated medication, or being unable to sustain long-term use financially
Semaglutide, originally developed for managing type 2 diabetes, have shown remarkable efficacy in promoting weight loss
